Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/2/07 18:34 | 7/10/07 | BIVN | Health | Drug | Pharmaceutical Preparations | Genzyme Corp | MA | T | P.ad | 47,029 | 5.60 | 0 | 8,398 | New | 8,398 | D | |||||||||||||||
7/16/07 14:33 | 7/10/07 | BIVN | Health | Drug | Pharmaceutical Preparations | Genzyme Corp | MA | T | P.ad | 48,236 | 5.60 | 0 | 8,614 | New | 8,614 | D | |||||||||||||||
7/11/07 20:23 | 7/10/07 | BIVN | Health | Drug | Pharmaceutical Preparations | Genzyme Corp | MA | T | P.d | 48,757 | 5.60 | 0 | 8,707 | New | 8,707 | D | |||||||||||||||
6/24/04 10:53 | 6/22/04 | BIV | Health | Drug | Pharmaceutical Preparations | Luci David P | NY | O | See Exhi | P | 8 | 8.25 | 0 | 1 | 14 | 8 | D | ||||||||||||||
5/17/04 17:41 | 5/13/04 | BIV | Health | Drug | Pharmaceutical Preparations | Perseus Soros Biopharmaceutical Fund LP | NY | T | P.d | 2,344 | 6.25 | 0 | 375 | New | 375 | D | |||||||||||||||
11/25/03 13:37 | 11/19/03 | BIV | Health | Drug | Pharmaceutical Preparations | Luci David P | NY | O | See Exhi | P | 24 | 3.40 | 0 | 7 | New | 7 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |